Caribou Biosciences, Inc. (CRBU)
NASDAQ: CRBU · Real-Time Price · USD
2.200
+0.050 (2.33%)
At close: Apr 17, 2026, 4:00 PM EDT
2.242
+0.042 (1.92%)
After-hours: Apr 17, 2026, 7:29 PM EDT
Caribou Biosciences Market Cap
Caribou Biosciences has a market cap or net worth of $212.6 million as of April 17, 2026. Its market cap has increased by 165.50% in one year.
Market Cap
212.60M
Enterprise Value
96.98M
1-Year Change
165.50%
Ranking
Category
Stock Price
$2.20
Market Cap Chart
Since the IPO on July 23, 2021, Caribou Biosciences's market cap has decreased from $888.48M to $212.60M, a decrease of -76.07%. That is a compound annual growth rate of -26.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2026 | 212.60M | 43.06% |
| Dec 31, 2025 | 148.61M | 3.22% |
| Dec 31, 2024 | 143.98M | -71.59% |
| Dec 29, 2023 | 506.71M | 32.27% |
| Dec 30, 2022 | 383.09M | -57.82% |
| Dec 31, 2021 | 908.30M | 2.23% |
| Jul 23, 2021 | 888.48M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| MediWound | 227.74M |
| Context Therapeutics | 223.27M |
| MacroGenics | 219.92M |
| ALX Oncology Holdings | 219.79M |
| Sagimet Biosciences | 210.83M |
| ProQR Therapeutics | 209.67M |
| Korro Bio | 207.54M |
| Enlivex | 204.03M |